Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

[1] Takimoto M(1982)Protective effect of Co Q 10 administration on cardiac toxicity in FAC therapy Gan To Kagaku Ryoho 9 116-21

[2] Sakurai T(2010)Cardiotoxicity of anthracyclin agents for the treatment of cancer: systematic review and meta-analysis of randomized controlled trials BMC Cancer 10 337-9

[3] Kodama K(2012)Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy Clin Breast Cancer 12 4-67

[4] Yokoi H(2011)Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper Ann Oncol 22 257-8

[5] Suzuki Y(2001)Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition Am J Clin Oncol 24 425-501

[6] Enomoto K(1998)Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients J Clin Oncol 16 3493-4

[7] Okada N(2001)Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous-infusion schedules Oncol Rep 8 611-89

[8] Smith LA(1984)Sensitivity and specificity of two-dimensional echocardiography in detection of impaired left ventricular function Eur Heart J 5 477-9

[9] Cornelius VR(2002)Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation J Med Liban 50 3-6

[10] Plummer CJ(2004)Prevention and management of cardiotoxicity from antineoplastic therapy J Support Oncol 2 251-undefined

[1] Takimoto M(1982)Protective effect of Co Q 10 administration on cardiac toxicity in FAC therapy Gan To Kagaku Ryoho 9 116-21

[2] Sakurai T(2010)Cardiotoxicity of anthracyclin agents for the treatment of cancer: systematic review and meta-analysis of randomized controlled trials BMC Cancer 10 337-9

[3] Kodama K(2012)Routine cardiac evaluation in patients with early-stage breast cancer before adjuvant chemotherapy Clin Breast Cancer 12 4-67

[4] Yokoi H(2011)Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper Ann Oncol 22 257-8

[5] Suzuki Y(2001)Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition Am J Clin Oncol 24 425-501

[6] Enomoto K(1998)Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients J Clin Oncol 16 3493-4

[7] Okada N(2001)Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous-infusion schedules Oncol Rep 8 611-89

[8] Smith LA(1984)Sensitivity and specificity of two-dimensional echocardiography in detection of impaired left ventricular function Eur Heart J 5 477-9

[9] Cornelius VR(2002)Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation J Med Liban 50 3-6

[10] Plummer CJ(2004)Prevention and management of cardiotoxicity from antineoplastic therapy J Support Oncol 2 251-undefined